chr1-197122013-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000367409.9(ASPM):c.3772G>A(p.Ala1258Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000552 in 1,612,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A1258A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000367409.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASPM | NM_018136.5 | c.3772G>A | p.Ala1258Thr | missense_variant | 16/28 | ENST00000367409.9 | NP_060606.3 | |
ASPM | NM_001206846.2 | c.3772G>A | p.Ala1258Thr | missense_variant | 16/27 | NP_001193775.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASPM | ENST00000367409.9 | c.3772G>A | p.Ala1258Thr | missense_variant | 16/28 | 1 | NM_018136.5 | ENSP00000356379 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000277 AC: 42AN: 151896Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000681 AC: 17AN: 249734Hom.: 0 AF XY: 0.0000740 AC XY: 10AN XY: 135068
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1460172Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 726440
GnomAD4 genome AF: 0.000277 AC: 42AN: 151896Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74192
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 01, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 28, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ASPM protein function. ClinVar contains an entry for this variant (Variation ID: 388993). This variant has not been reported in the literature in individuals affected with ASPM-related conditions. This variant is present in population databases (rs142214506, gnomAD 0.09%). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1258 of the ASPM protein (p.Ala1258Thr). - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 22, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at